Nobelpharma
nobelpharma.co.jpTotal trials
34
Active
0
Phase 3
25
Total enrollment
2,156
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Dysmenorrhea6
- Zinc Deficiency2
- Sleep Disorders2
- Healthy2
- Tuberous Sclerosis2
- Angiofibroma2
- Hypomelanotic Macule2
- Plaque2
Frequently asked questions about Nobelpharma
- How many clinical trials does Nobelpharma have on ClinicalTrials.gov?
- Nobelpharma is listed as the lead sponsor on 34 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nobelpharma's trials are in Phase 3?
- 25 of Nobelpharma's trials are in Phase 3.
- What therapeutic areas does Nobelpharma focus on?
- Nobelpharma's most-studied conditions on ClinicalTrials.gov are Dysmenorrhea, Zinc Deficiency, Sleep Disorders, Healthy, Tuberous Sclerosis.